WWM
BIIB icon

Western Wealth Management’s Biogen BIIB Stock Holding History

Western Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Sell
1,183
-71
-6% -$13.1K 0.01% 895
2025
Q4 		$221K Buy
+1,254
New +$205K 0.01% 773
2025
Q1 		– Sell
-1,484
Closed -$227K – 682
2024
Q4 		$227K Sell
1,484
-100
-6% -$16.9K 0.01% 604
2024
Q3 		$307K Sell
1,584
-53
-3% -$11.1K 0.02% 589
2024
Q2 		$379K Sell
1,637
-30
-2% -$6.52K 0.03% 434
2024
Q1 		$359K Buy
1,667
+136
+9% +$31.9K 0.03% 449
2023
Q4 		$396K Buy
1,531
+7
+0.5% +$1.72K 0.03% 466
2023
Q3 		$392K Sell
1,524
-47
-3% -$12.6K 0.03% 440
2023
Q2 		$448K Sell
1,571
-2
-0.1% -$595 0.04% 400
2023
Q1 		$437K Sell
1,573
-5
-0.3% -$1.38K 0.04% 401
2022
Q4 		$437K Sell
1,578
-1,135
-42% -$321K 0.04% 367
2022
Q3 		$727K Sell
2,713
-1,602
-37% -$340K 0.04% 388
2022
Q2 		$877K Sell
4,315
-375
-8% -$76.7K 0.05% 332
2022
Q1 		$988K Buy
4,690
+3,200
+215% +$696K 0.05% 336
2021
Q4 		$352K Buy
+1,490
New +$383K 0.03% 419
2021
Q2 		$397K Buy
1,147
+104
+10% +$31.5K 0.04% 418
2021
Q1 		$292K Sell
1,043
-127
-11% -$34.3K 0.04% 407
2020
Q4 		$286K Buy
1,170
+2
+0.2% +$516 0.04% 366
2020
Q3 		$331K Buy
1,168
+49
+4% +$13.7K 0.05% 315
2020
Q2 		$299K Sell
1,119
-3
-0.3% -$902 0.05% 313
2020
Q1 		$357K Buy
1,122
+199
+22% +$60.4K 0.08% 240
2019
Q4 		$274K Hold
923
– – 0.04% 330
2019
Q3 		$213K Buy
+923
New +$215K 0.04% 363
2019
Q1 		– Sell
-740
Closed -$227K – 380
2018
Q4 		$227K Buy
+740
New +$236K 0.06% 302

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Western Wealth Management's BIIB Position: Q1 2026 in Review

Western Wealth Management reduced its Biogen (BIIB) stake by 5.7% in Q1 2026, selling an estimated $13.1K and leaving 1,183 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #895.

Western Wealth Management first reported a position in BIIB in Q4 2018 and has held it in 24 quarters since. The position peaked at $988K in Q1 2022. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Western Wealth Management held 1,183 shares of Biogen worth $217K as of Q1 2026.
  • Western Wealth Management sold 71 Biogen shares in Q1 2026, an estimated $13.1K.
  • Biogen made up 0.01% of Western Wealth Management's portfolio in Q1 2026, its #895 holding.
  • Western Wealth Management first reported a position in Biogen in Q4 2018 and has held it in 24 quarters since.
  • Western Wealth Management's Biogen position peaked at $988K in Q1 2022.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Western Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.